Compositions, devices and methods for treating autism
OwnerThomas Julius Borodyinventor
Life of this patent
Estimating the term…
Abstract
In alternative embodiments, provided are pharmaceutical compositions and methods for treating, ameliorating, reversing and/or preventing (acting as a prophylaxis) autism, e.g., regressive autism. In alternative embodiments, these pharmaceutical compositions and methods are dosaged and administered to children in need thereof. In alternative embodiments, pharmaceutical compositions and methods are dosaged, formulated and dosaged as solid, liquid or aerosol preparations or formulations. In alternative embodiments, pharmaceutical compositions comprise rifaximin as the sole antibiotic, or rifaximin and other antimicrobial or antibiotic agent, for example, vancomycin, metronidazole, tinidazole or a combination thereof.
Claims21
A method for treating, ameliorating, reversing and/or preventing an autism or an autism spectrum disorder (ASD),
- optionally a regressive autism setback-type autism, or an acquired autistic syndrome, in an individual in need thereof,
- comprising administering to the individual in need thereof a formulation, a pharmaceutical preparation or a pharmaceutical composition comprising:
- (a) a rifaximin, an extended intestinal release (EIR) rifaximin, a rifamycin derivative, a rifampicin (or rifampin), a rifabutin, a rifapentine, a rifalazil, a bicozamycin, or a mixture or combination thereof, or
- (b) a rifaximin and at least one additional antimicrobial or antibiotic agent,
- wherein optionally the at least one additional antimicrobial or antibiotic agent comprises a vancomycin, a metronidazole, a tinidazole or a combination thereof.
(canceled)
Dependencies are inferred from the claim text.